SG Americas Securities’s Arbutus Biopharma ABUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $72K | Sell |
23,376
-26,594
| -53% | -$81.9K | ﹤0.01% | 2380 |
|
|
2025
Q1 | $174K | Sell |
49,970
-19,149
| -28% | -$66.7K | ﹤0.01% | 2346 |
|
|
2024
Q4 | $226K | Buy |
69,119
+16,250
| +31% | +$53.1K | ﹤0.01% | 1793 |
|
|
2024
Q3 | $204K | Buy |
+52,869
| New | +$204K | ﹤0.01% | 2199 |
|
|
2024
Q2 | – | Sell |
-19,644
| Closed | -$51K | – | 2387 |
|
|
2024
Q1 | $51K | Sell |
19,644
-26,528
| -57% | -$68.9K | ﹤0.01% | 2431 |
|
|
2023
Q4 | $115K | Buy |
46,172
+6,117
| +15% | +$15.2K | ﹤0.01% | 2428 |
|
|
2023
Q3 | $81K | Buy |
+40,055
| New | +$81K | ﹤0.01% | 2570 |
|
|
2023
Q2 | – | Sell |
-52,397
| Closed | -$159K | – | 1901 |
|
|
2023
Q1 | $159K | Buy |
52,397
+27,016
| +106% | +$82K | ﹤0.01% | 2365 |
|
|
2022
Q4 | $59K | Sell |
25,381
-4,094
| -14% | -$9.52K | ﹤0.01% | 2552 |
|
|
2022
Q3 | $56K | Buy |
29,475
+7,957
| +37% | +$15.1K | ﹤0.01% | 2660 |
|
|
2022
Q2 | $58K | Buy |
21,518
+8,274
| +62% | +$22.3K | ﹤0.01% | 2949 |
|
|
2022
Q1 | $39K | Sell |
13,244
-8,381
| -39% | -$24.7K | ﹤0.01% | 2514 |
|
|
2021
Q4 | $84K | Sell |
21,625
-577,724
| -96% | -$2.24M | ﹤0.01% | 2812 |
|
|
2021
Q3 | $2.57M | Buy |
+599,349
| New | +$2.57M | 0.01% | 944 |
|
|
2019
Q4 | – | Sell |
-35,701
| Closed | -$54K | – | 2663 |
|
|
2019
Q3 | $54K | Sell |
35,701
-37,397
| -51% | -$56.6K | ﹤0.01% | 2380 |
|
|
2019
Q2 | $152K | Buy |
73,098
+15,644
| +27% | +$32.5K | ﹤0.01% | 2213 |
|
|
2019
Q1 | $206K | Buy |
57,454
+9,078
| +19% | +$32.5K | ﹤0.01% | 2224 |
|
|
2018
Q4 | $185K | Sell |
48,376
-56,480
| -54% | -$216K | ﹤0.01% | 2063 |
|
|
2018
Q3 | $991K | Buy |
+104,856
| New | +$991K | 0.01% | 1521 |
|